NCT05240586

Brief Summary

This is pilot study for a 3-arm parallel pragmatic randomized controlled trial that will compare pharmacopuncture therapy, acupunture therapy and physical therapy, medication(prn) for cervical disc herniation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2022

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 13, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 15, 2022

Completed
2 months until next milestone

Study Start

First participant enrolled

April 20, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 26, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 26, 2023

Completed
Last Updated

March 14, 2025

Status Verified

March 1, 2025

Enrollment Period

1.1 years

First QC Date

February 13, 2022

Last Update Submit

March 12, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Numeric rating scale (NRS) of neck pain

    NRS is a pain scale in which the patient indicates their subjective pain as a whole number from 0 to 10, where 0 indicates 'no pain or discomfort' and 10 indicates 'the most severe pain and discomfort imaginable'.

    Week 1, 2, 3, 4, 5, 6, 7, 13, 25

Secondary Outcomes (7)

  • Numeric rating scale (NRS) of radiating arm pain

    Week 1, 2, 3, 4, 5, 6, 7, 13, 25

  • Visual analogue scale (VAS) of neck pain and radiating arm pain

    Week 1, 2, 3, 4, 5, 6, 7, 13, 25

  • Neck Disability Index (NDI)

    Week 1, 7, 13, 25

  • Northwick Park Questionnaire (NPQ)

    Week 1, 7, 13, 25

  • Patient Global Impression of Change (PGIC)

    Week 7, 13, 25

  • +2 more secondary outcomes

Study Arms (3)

pharmacopunture therapy

EXPERIMENTAL

The physicians will choose the type and volume of pharmacopuncture according to participants' conditions.

Procedure: pharmacopuncture therapy

acupuncture therapy

ACTIVE COMPARATOR

The physicians will choose the type and number of acupuncture therapy according to participants' conditions.

Procedure: acupuncture therapy

physical therapy, medication(prn)

ACTIVE COMPARATOR

The physicians will choose the type and time of physical therapy according to participants' conditions. According to clinical judgment, clinicians can prescribe analgesics and muscle relaxants if necessary.

Procedure: physical therapy, medication(prn)

Interventions

This is a pragmatic RCT, so the physicians will choose the type and volume of pharmacopuncture according to participants' conditions.

pharmacopunture therapy

This is a pragmatic RCT, so the physicians will choose the type and number of acupuncture therapy according to participants' conditions.

acupuncture therapy

This is a pragmatic RCT, so the physicians will choose the type and time of physical therapy according to participants' conditions. According to clinical judgment, clinicians can prescribe analgesics and muscle relaxants if necessary.

physical therapy, medication(prn)

Eligibility Criteria

Age19 Years - 69 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Symptoms of cervical disc herniation for less than 12 months
  • Numeric Rating Scale (NRS) of neck pain is more than 5
  • Symptoms of neuromuscular disease in one or both upper limbs (pain, pull, numbness, sensory abnormalities, motor abnormalities)
  • Discrimination findings above protusion, which can explain clinical symptoms on Cervical spine MRI or CT
  • years old
  • participants who agreed and wrote informed consents

You may not qualify if:

  • Case of being diagnosed with a specific serious disease that may cause neck pain(Migration of cancer reaching to spine, acute fracture of spine, spine dislocation)
  • Progressive neurologic deficits or severe neurologic deficits
  • Cause of pain due to soft tissue disease, not the spine(Cancer, fibromyalgia, RA, goat, or etc.)
  • Other chronic diseases(stroke, MI, kidney disease, diabetic neuropathy, dimentia, epilepsy, or etc.) that may interfere with the interpretation of therapeutic effects or outcomes
  • Participants taking steroid, immunosuppressant, psychotropic medication, or taking other drugs that may affect outcomes
  • Inappropriate or unsafe pharmacopuncture therapy; hemorrhagic disease, taking anticoagulant drug, or severe diabetes patients who are likely to be infected
  • Participants who took NSAIDs or pharmacopuncture, acupuncture, physical therapy within 1 week
  • Pregnant, planning to get pregnant or lactating women
  • Participants who had undergone cervical surgery within 3 months
  • Participants who had participated in other clinical trial within 1 month, had participated in other study within 6 months from the date of selection, or have plan for participation in other trial during follow up period of this trial
  • Participants who can not write informed consent
  • Participants who is difficult to participate in the trial according to investigator's decision

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Kyung Hee University Korean Medicine Hospital

Seoul, Dongdaemun-gu, 130-701, South Korea

Location

Kyung Hee University Korean Medicine Hospital at Gangdong

Seoul, Gangdong-gu, 05278, South Korea

Location

Jaseng Hospital of Korean Medicine

Seoul, Gangnam-Gu, 135-896, South Korea

Location

Bucheon Jaseng Hospital of Korean Medicine

Bucheon-si, Gyeonggi Province, 14598, South Korea

Location

Dongguk University Bundang Oriental Hospital

Seongnam-si, Gyeonggi-do, 13601, South Korea

Location

Haeundae Jaseng Hospital of Korean Medicine

Busan, South Korea

Location

Daejeon Jaseng Hospital of Korean Medicine

Daejeon, 35262, South Korea

Location

MeSH Terms

Interventions

Acupuncture TherapyPhysical Therapy Modalities

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsRehabilitation

Study Officials

  • In-Hyuk Ha, Ph.D.

    Jaseng Medical Foundation

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

February 13, 2022

First Posted

February 15, 2022

Study Start

April 20, 2022

Primary Completion

May 26, 2023

Study Completion

September 26, 2023

Last Updated

March 14, 2025

Record last verified: 2025-03

Locations